AVEO
AVEO Pharmaceuticals, Inc.
AVEO
AVEO
Delisted
AVEO was delisted on the 19th of January, 2023.
55 hedge funds and large institutions have $21.4M invested in AVEO Pharmaceuticals, Inc. in 2014 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 13 increasing their positions, 18 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding in top 10
Funds holding in top 10: →
less first-time investments, than exits
New positions opened: | Existing positions closed:
49% less capital invested
Capital invested by funds: $42.3M → $21.4M (-$20.9M)
97% less call options, than puts
Call options by funds: $4K | Put options by funds: $124K
Holders
55
Holding in Top 10
2
Calls
$4K
Puts
$124K
Top Buyers
| 1 | +$1.05M | |
| 2 | +$274K | |
| 3 | +$216K | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$191K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$190K |
Top Sellers
| 1 | -$4.25M | |
| 2 | -$1.23M | |
| 3 | -$956K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$531K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$409K |